Müller M J, Pirlich M, Balks H J, Selberg O
Abteilung Gastroenterologie und Hepatologie, Medizinische Hochschule Hannover, Germany.
Eur J Clin Chem Clin Biochem. 1994 Oct;32(10):749-58. doi: 10.1515/cclm.1994.32.10.749.
Oral glucose tolerance was tested in a heterogeneous group of 108 patients with liver cirrhosis. Data were compared with those from 181 subjects without liver disease (44% normal, 35% impaired glucose tolerance and 21% type 2 diabetes mellitus). In cirrhosis, 27% of the patients had normal, 36% had impaired glucose tolerance, and 37% were diabetic. There was no association between glucose intolerance or diabetes and the aetiology of cirrhosis, the duration of the disease, the biochemical indicators of hepatocyte damage, cholestasis and/or liver function. Only weak associations were found between the results of quantitative liver functions tests (caffeine, xylocaine, indocyanine green) and basal and post load glucose and insulin concentrations. Cirrhotics with 1st degree relatives with type 2 diabetes mellitus (n = 16) did not show an increased prevalence of diabetes. Older and/or malnourished patients were more frequently glucose intolerant. Using the plasma glucose concentration 120 minutes after glucose load as the dependent variable, multivariate regression analysis showed that 54% of its variance is associated with the following variables: basal plasma glucose (36%) and free fatty acid concentration (5%), age (3%), basal glucose oxidation rate (3%), muscle mass (3%) and plasma free glycerol at 120 minutes after glucose load (3%). By contrast, the clinical state of the patients (i.e. the CHILD-Pugh score) accounted for only 2% of the variance. We conclude that glucose tolerance is variable in cirrhosis. After manifestation of liver disease, glucose intolerance or diabetes cannot be explained by the clinical, histological or biochemical signs of liver disease.
对108例肝硬化患者组成的异质性群体进行了口服葡萄糖耐量测试。将数据与181名无肝脏疾病受试者的数据进行比较(44%正常,35%葡萄糖耐量受损,21%为2型糖尿病)。在肝硬化患者中,27%的患者葡萄糖耐量正常,36%葡萄糖耐量受损,37%为糖尿病患者。葡萄糖不耐受或糖尿病与肝硬化的病因、病程、肝细胞损伤的生化指标、胆汁淤积和/或肝功能之间无关联。仅在定量肝功能试验(咖啡因、利多卡因、吲哚菁绿)结果与基础及负荷后血糖和胰岛素浓度之间发现了微弱关联。有2型糖尿病一级亲属的肝硬化患者(n = 16)糖尿病患病率并未增加。年龄较大和/或营养不良的患者更常出现葡萄糖不耐受。以葡萄糖负荷后120分钟的血浆葡萄糖浓度作为因变量,多元回归分析显示其54%的变异与以下变量相关:基础血浆葡萄糖(36%)、游离脂肪酸浓度(5%)、年龄(3%)、基础葡萄糖氧化率(3%)、肌肉量(3%)以及葡萄糖负荷后120分钟的血浆游离甘油(3%)。相比之下,患者的临床状态(即Child-Pugh评分)仅占变异的2%。我们得出结论,肝硬化患者的葡萄糖耐量存在差异。在肝脏疾病出现后,葡萄糖不耐受或糖尿病无法通过肝脏疾病的临床、组织学或生化体征来解释。